Nektar Therapeutics
NKTR
#6498
Rank
NZ$1.26 B
Marketcap
NZ$61.98
Share price
5.96%
Change (1 day)
177.28%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2025 (TTM): NZ-$13.62

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ-$13.23. In 2024 the company made an earnings per share (EPS) of NZ-$14.71 an increase over its 2023 EPS that were of NZ-$36.36.

EPS history for Nektar Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$13.62-7.42%
2024NZ-$14.71-59.54%
2023NZ-$36.36-25.89%
2022NZ-$49.06-31.12%
2021NZ-$71.2314.86%
2020NZ-$62.02-1.19%
2019NZ-$62.76-163.96%
2018NZ$98.13-725.4%
2017NZ-$15.69-42.73%
2016NZ-$27.4083.33%
2015NZ-$14.9439.53%
2014NZ-$10.71-69.29%
2013NZ-$34.87-6.67%
2012NZ-$37.36

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$17.33-230.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.86-121.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$21.64-263.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
NZ-$1.10-91.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.61-195.28%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$5.04-138.08%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
NZ$0.12-100.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
NZ$3.44-125.97%๐Ÿ‡ฎ๐Ÿ‡ช Ireland